发明申请
- 专利标题： NOVEL THIAZOLIDIN-4-ONE DERIVATIVES
- 专利标题（中）： 新型噻唑烷-4-酮衍生物
-
申请号： US12026277申请日： 2008-02-05
-
公开(公告)号： US20080146629A1公开(公告)日： 2008-06-19
- 发明人: Christoph Binkert , Martin Bolli , Boris Mathys , Claus Mueller , Michael Scherz , Oliver Nayler
- 申请人： Christoph Binkert , Martin Bolli , Boris Mathys , Claus Mueller , Michael Scherz , Oliver Nayler
- 申请人地址： CH Allschwil
- 专利权人： ACTELION PHARMACEUTICALS, LTD.
- 当前专利权人： ACTELION PHARMACEUTICALS, LTD.
- 当前专利权人地址： CH Allschwil
- 优先权： EPPCT/EP03/13072 20031121
- 主分类号： A61K31/426
- IPC分类号： A61K31/426 ; C07D277/38
摘要：
The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.
公开/授权文献
- US07626037B2 Thiazolidin-4-one derivatives 公开/授权日：2009-12-01
信息查询
IPC分类:
